Literature DB >> 19467870

Comment on "Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin".

Eric J Buenz.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19467870     DOI: 10.1016/j.jocn.2008.11.004

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


× No keyword cloud information.
  1 in total

1.  Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome.

Authors:  Jeffrey L Winters; David Brown; Elisabeth Hazard; Ashok Chainani; Chester Andrzejewski
Journal:  BMC Health Serv Res       Date:  2011-05-16       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.